Chromosomal aberrations and common fragile sites in neuroblastoma patients

P. Vernole, B. Tedeschi, C. Pianca, B. Nicoletti, R. Riccardi, G. Melino

Research output: Contribution to journalArticle

Abstract

We analyzed cytogenetically blood cells and bone marrow cells from 20 neuroblastoma patients. Chromosome common fragile sites were induced by aphidicolin in normal peripheral blood lymphocytes. All neuroblastoma patients showed a higher increase of aberrations after aphidicolin treatment as compared to that found in normal controls. In some cases it was possible to correlate the increase of the expression of a specific fragile site, 1p32, with deletions in the same area in bone marrow cells.

Original languageEnglish
Pages (from-to)247-251
Number of pages5
JournalClinical Chemistry and Enzymology Communications
Volume2
Issue number4-6
Publication statusPublished - 1990

Fingerprint

Aphidicolin
Aberrations
Neuroblastoma
Chromosome Aberrations
Bone Marrow Cells
Chromosome Fragile Sites
Cells
Bone
Blood
Blood Cells
Lymphocytes
Chromosomes
Therapeutics
Monosomy 1p32 Chromosome 1

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Vernole, P., Tedeschi, B., Pianca, C., Nicoletti, B., Riccardi, R., & Melino, G. (1990). Chromosomal aberrations and common fragile sites in neuroblastoma patients. Clinical Chemistry and Enzymology Communications, 2(4-6), 247-251.

Chromosomal aberrations and common fragile sites in neuroblastoma patients. / Vernole, P.; Tedeschi, B.; Pianca, C.; Nicoletti, B.; Riccardi, R.; Melino, G.

In: Clinical Chemistry and Enzymology Communications, Vol. 2, No. 4-6, 1990, p. 247-251.

Research output: Contribution to journalArticle

Vernole, P, Tedeschi, B, Pianca, C, Nicoletti, B, Riccardi, R & Melino, G 1990, 'Chromosomal aberrations and common fragile sites in neuroblastoma patients', Clinical Chemistry and Enzymology Communications, vol. 2, no. 4-6, pp. 247-251.
Vernole, P. ; Tedeschi, B. ; Pianca, C. ; Nicoletti, B. ; Riccardi, R. ; Melino, G. / Chromosomal aberrations and common fragile sites in neuroblastoma patients. In: Clinical Chemistry and Enzymology Communications. 1990 ; Vol. 2, No. 4-6. pp. 247-251.
@article{a549ea6d1edc46a080a15649cf0c1fef,
title = "Chromosomal aberrations and common fragile sites in neuroblastoma patients",
abstract = "We analyzed cytogenetically blood cells and bone marrow cells from 20 neuroblastoma patients. Chromosome common fragile sites were induced by aphidicolin in normal peripheral blood lymphocytes. All neuroblastoma patients showed a higher increase of aberrations after aphidicolin treatment as compared to that found in normal controls. In some cases it was possible to correlate the increase of the expression of a specific fragile site, 1p32, with deletions in the same area in bone marrow cells.",
author = "P. Vernole and B. Tedeschi and C. Pianca and B. Nicoletti and R. Riccardi and G. Melino",
year = "1990",
language = "English",
volume = "2",
pages = "247--251",
journal = "Clinical Chemistry and Enzymology Communications",
issn = "0892-2187",
publisher = "Harwood Academic Publishers",
number = "4-6",

}

TY - JOUR

T1 - Chromosomal aberrations and common fragile sites in neuroblastoma patients

AU - Vernole, P.

AU - Tedeschi, B.

AU - Pianca, C.

AU - Nicoletti, B.

AU - Riccardi, R.

AU - Melino, G.

PY - 1990

Y1 - 1990

N2 - We analyzed cytogenetically blood cells and bone marrow cells from 20 neuroblastoma patients. Chromosome common fragile sites were induced by aphidicolin in normal peripheral blood lymphocytes. All neuroblastoma patients showed a higher increase of aberrations after aphidicolin treatment as compared to that found in normal controls. In some cases it was possible to correlate the increase of the expression of a specific fragile site, 1p32, with deletions in the same area in bone marrow cells.

AB - We analyzed cytogenetically blood cells and bone marrow cells from 20 neuroblastoma patients. Chromosome common fragile sites were induced by aphidicolin in normal peripheral blood lymphocytes. All neuroblastoma patients showed a higher increase of aberrations after aphidicolin treatment as compared to that found in normal controls. In some cases it was possible to correlate the increase of the expression of a specific fragile site, 1p32, with deletions in the same area in bone marrow cells.

UR - http://www.scopus.com/inward/record.url?scp=0025253438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025253438&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025253438

VL - 2

SP - 247

EP - 251

JO - Clinical Chemistry and Enzymology Communications

JF - Clinical Chemistry and Enzymology Communications

SN - 0892-2187

IS - 4-6

ER -